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The National Heart, Lung, and Blood Institute (NHLBI) has recognized the importance
of the systems biology approach for understanding normal physiology and perturbations
associated with heart, lung, blood, and sleep diseases and disorders. In 2006, NHLBI
announced the Exploratory Program in Systems Biology program, followed in 2010 by the
NHLBI Systems Biology Collaborations program. The goal of these programs is to support
collaborative teams of investigators in using experimental and computational strategies
to integrate the component parts of biological networks and pathways into computational
models that are based firmly on and validated using experimental data. These validated
models are then applied to gain insights into the mechanisms of altered system function
in disease, to generate novel hypotheses regarding these mechanisms that can be tested
experimentally, and to then use the results of experiments to refine the models. This
perspective reviews the history of dedicated systems biology programs at NHLBI and
reviews some promising directions for future research in this area.
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Systems biology aims to help us understand and predict the
behavior of complex systems through a combination of exper-
imental and computational approaches with each approach
informing the other. Although high-throughput omic technolo-
gies may help inform a systems approach, such approaches alone
do not constitute a systems biology research program. Similarly,
while systems biology research requires computational modeling,
neither does simply doing modeling encompass a systems biology
program. Indeed, systems biology research requires both compu-
tational and experimental (often high-throughput) approaches
in research program that complement and inform each other.
Experiments measure the system and its key properties and
responses, while computational models integrate the informa-
tion and generate new testable hypotheses. This combination of
experimental and computational approaches have been helping to
improve the understanding of complex systems in heart, lung, and
blood research for decades, and is particularly useful in under-
standing and even predicting the emergent properties of these
systems, whose responses and characteristics may be greater than
the sum of their parts. A critical early exemplar of the usefulness
and impact of such approaches is Denis Noble’s computational
modeling of the cardiac action potential (Noble, 1962), which
demonstrated that cardiac action potential results from interac-
tions between multiple ion channels. His model helped form the
basis of an active and growing cardiac simulation research com-
munity that continues to improve upon the models to refine their
predictive ability and usefulness (Trayanova et al., 2012). These
and other exemplars demonstrate the promise that the systems
biology approach may hold to better understand complex sys-
tems, their dysfunction in disease, and support development of
new therapies.
SYNOPSIS OF NHLBI ACTIVITIES TO DATE
Over the past 8 years, the National Heart, Lung, and Blood
Institute (NHLBI) has invested in targeted programs to foster
such integrated experimental and computational approaches in
promising areas throughout the heart, lung, blood, and sleep
research portfolio. Guided by input from a working group in
2004, “A Systems Biology Approach to Regulatory Networks in
Heart, Lung, Blood and Sleep Research” that was chaired by Drs.
Leroy Hood and Joseph Nadeau, NHLBI targeted its investment
in systems biology to support research collaborations between
computational and experimental researchers focused on specific
research challenges.
The Request for Application (RFA) “NHLBI Exploratory
Program in Systems Biology (R33),” HL06-004 and HL07-005,
was designed to foster these multi-disciplinary collaborations
that required integration of different types of expertise (pre-
dictive computational models, informatics, and experimental
systems). To emphasize the importance of the balance and inte-
gration of these different approaches to the overall project,
this program supported independent, linked R33 awards to
the different collaborating investigators in the project. This
multiple linked award approach was necessary as this pro-
gram pre-dated the National Institutes of Health Multiple
Principle Investigator policy (http://grants.nih.gov/grants/guide/
notice-files/NOT-OD-07-017.html).
These linked R33 awards independently supported both the
computational and experimental investigators while requiring
them to work closely together to produce a single coherent, inte-
grated project. The R33 mechanism was used to emphasize the
high risk, innovative science this program intended to support.
These R33 awards were not renewable, and successful projects
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were expected to be competitive for subsequent investigator-
initiated research proposals. To allow research communities in
different stages of readiness to respond, the RFA was designed
with multiple receipt dates and funded projects starting in 2006,
2007, and 2008. In the past, others have provided excellent reviews
of the systems biology (Chuang et al., 2010; MacIlwain, 2011;
Hood and Tian, 2012), here we provide an overview of the NHLBI
support and development of the systems biology field as it applies
to heart, lung, and blood research.
The “NHLBI Exploratory Program in Systems Biology” pro-
gram was successful in developing this field across NHLBI
research areas. Although NHLBI originally set aside $24.3 mil-
lion to support nine awards, a total of twelve projects were funded
for the RFA, given the number of high-quality applications. Some
examples of the diversity of research supported through this
program included “Blood Systems Biology,” “Systems Biology
of Sudden Cardiac Death,” to the “Neurogenesis of Cough.”
Modeling approaches in these projects ranged from physics-based
models, to agent-based models, to analysis of signaling networks.
As this program encouraged multi-scale modeling, many of the
proposals included multiple modeling approaches to address
challenges at the different scales within the system. Following this
successful RFAs -program, NHLBI continues to support this area
by transitioning this program from RFA with a set-aside budget
to an ongoing Program Announcement (PA), “NHLBI Systems
Biology Collaborations (R01)”- PAR09-214. This PA was released
in 2009 and had two receipt dates per year but retained a spe-
cial emphasis panel for review. Between these targeted funding
opportunities (RFA-HL-06-004, RFA-HL-07-005, and PAR09-
214), NHLBI has committed $45.6M between 2006 and 2012 to
support systems biology research. NHLBI continues to support
this PA through the renewal PAR12-138 that is active till 2015.
The purpose of this program was to build a community of
researchers interested in developing, applying, and sharing sys-
tems biology approaches to the wide variety of research challenges
represented across NHLBI research. This has been successful
through both the original RFA program and through the vari-
ous other programs supported from NHLBI. The success of this
has also been shown through the large and vibrant group of
HLBS researchers funded through the Interagency Modeling and
Analysis Group’s Multi-Scale Modeling program (IMAG/MSM).
Indeed, the NHLBI systems biology program and the MSM pro-
grams have held joint meetings for the last 3 years, because
of the shared research interests between the programs. These
interactive meetings allow cross-cutting discussions across diverse
research areas that help keep researchers informed about innova-
tive new computational approaches of potential interest to their
own research area.
An analysis of research funding of systems biology research
using the NIH Reporter system (http://projectreporter.nih.gov/
reporter.cfm) showed a marked growth in NHLBI systems biol-
ogy research over the last 8 years (2006–2012). NHLBI support
of research in this area through targeted announcements was
assessed by searching the NIH Reporter database for grants
funded through targeted funding opportunities RFA-HL-06-004,
RFA-HL-07-005, or PAR-09-214. We determined number of
awards, total costs, and number of publications in each year for
each award. To determine the overall investment in the systems
biology field, the same measures were taken for a search of grants
that included the term “systems biology” in the title, abstract,
or specific aims. This general search included only R21, R13,
R33, and R01-equivalent grant mechanisms, excluding Program
Projects (P01) and cooperative agreements. This analysis showed
that the targeted funding announcements were responsible for the
vast majority of systems biology projects supported by NHLBI
from 2006 to 2009 (See Figure 1). However, starting in 2009,
funding from these targeted announcements leveled off to about
$5M–$7M per year, while the overall systems biology portfolio
increased dramatically starting in 2009. Analysis of the output
of the three targeted programs through publications shows an
expected lag, with publications increasing from 2006 to 2009 then
remaining steady, as it takes several years for the fruits of research
to result in publications.
A visualization of the key terms from the grants identified from
the overall “systems biology” analysis from NIH Reporter identi-
fies overall themes across the portfolio (See Figure 2). The most
common terms were “mathematical model,” “gene expression,”
“candidate gene,” “stem cells,” and “heart failure.” This analysis
shows the diversity of scientific areas across the NHLBI portfolio
using the systems biology approach: from heart failure, airway,
and epithelial cell biology, to blood cell and stem cell regulation
and infection. Approaches such as gene expression cut across dis-
ease areas, from pulmonary fibrosis, blood cells, to cardiovascular
disease. This visualization gives a snapshot of the current NHLBI
systems biology portfolio and highlights areas of strength and its
diversity.
GOING FORWARD
Going forward we hope to see continued growth of systems
biology approaches to diverse research challenges, where they
are useful and appropriate, as the integration of computa-
tional and biological/experimental methodologies can provide
greater insight to complex biology. One area of particular
interest is the potential of systems biology to help guide and
accelerate translational research. For instance, an integrated
systems level approach may prove useful in accelerating tar-
geted drug development and reduced off-target drug effects
(Sorger and Allerheiligen, 2011). Systems approaches may also
help quantify behavioral influences on disease propensity. Such
integration across physiological, genetic, and behavioral mod-
els is identified as a challenge in the current Interagency
Multi-Scale Modeling Initiative, “Predictive Multiscale Models
for Biomedical, Biological, Behavioral, Environmental and
Clinical Research (Interagency U01)” (http://grants.nih.gov/
grants/guide/pa-files/PAR-11-203.html).
Another developing area of interest is personalized precision
medicine that promises individualized modeling to refine and
target treatments to each person. While earlier examples of per-
sonalized medicine were seen in the field of pharmacogenomics
(Jiayi et al., 2009), precision medicine includes a variety of differ-
ent research areas, explicitly including mathematical modeling.
For example in the cardiovascular arena, personalized models
of the cardiovascular system are being developed that incorpo-
rate image-based information about the heart or major vessels
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FIGURE 1 | (A) NHLBI investment-Legend-NHLBI invested over $45M in
systems biology targeted FOAs through between 2006 and 2012. (B) # of
projects-Legend-For the first three years, the targeted systems biology
FOAs make up most of the awards in the NHLBI portfolio. But as RFA
funding ends, the number of awards self-identifying as systems biology
projects increases (2011 and beyond). (C) # of
publications-Legend-Publications from the targeted FOAs gain impact in
1–3 year lag following funding, continuing to increase through 2011,
although funding peaked for targeted FAOs in 2008. (D) Amount of $ on
grants/year-Legend- Through 2008, virtually all funding goes to the RFA
awards. However other (non-FOA) systems biology grants accelerate
rapidly from 2009 to 2012.
FIGURE 2 | NIH Reporter visualization of themes across the NHLBI
systems biology portfolio (2006–2012).
from individual patients to generate predictive models tailored
to that individual. Examples range from patient-specific models
of cardiovascular mechanics (Krishnamurthy et al., 2013), to pre-
surgical patient-specific aneurismmodels that help surgeons plan
the surgery for each patient (Xiao et al., 2013), to application of
individualized mathematical predictive models of blood flow in
coronary arteries (Pijls and Sels, 2012), which has become a gold
standard for invasive assessment of physiologic stenosis and an
indispensable tool for decision making in coronary revasculariza-
tion. Additionally, evidence that systems biology approaches have
the potential to improve translation is the FDA approval of infu-
sion pumps based on comprehensive models for diabetes. Models
accurately recreated the precise and dynamic glucose-regulating
function of a healthy pancreas (Kovatchev et al., 2009; Zhang
et al., 2010).
Another area of interest is network-based approaches that seek
to provide new insights into health and disease, by understand-
ing complex interactions at the scale of individuals, tissues, or
cells and the impact of disease state or therapeutics on disturb-
ing these networks. One example is the Common Fund Library of
Integrated Network based Cellular Signals (LINCS, http://www.
lincsproject.org/) managed jointly by NHLBI and the National
Human Genome Institute (NHGRI). LINCS aims to create a
network-based understanding of biology by cataloging changes
in gene expression and other cellular processes that occur when
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cells are exposed to a variety of perturbing agents and by using
computational tools to integrate this diverse information into
a comprehensive view of normal and disease states that can
be applied for the development of new biomarkers and thera-
peutics. Another NHLBI program designed to utilize evolving
knowledge of cellular and molecular networks to define com-
mon mechanism-associated traits across organ systems is Cross
Organ Mechanism-Associated Phenotypes for Genetic Analyses
of Heart, Lung, Blood, and Sleep Diseases (MAPGen, http://
mapgenprogram.com/). The program identifies and character-
izes common pathobiologic traits and/or mechanisms that cross
organ systems and diseases with the ultimate goal of redefin-
ing heart, lung, blood, and sleep disorders based on newfound
knowledge of the underlying molecular and/or cellular pathobi-
ology. More recently, research in the MapGen program is mak-
ing important strides to highlight our understanding of cellular
networks and their relation to human diseasome, which may
help foster network medicine (Barabasi et al., 2011; Chan and
Loscalzo, 2012). Given the functional interdependencies between
the molecular components in a human cell, a disease is rarely a
consequence of an abnormality in a single gene but reflects the
perturbations of the complex intracellular network (Loscalzo and
Barabasi, 2011). The hope is that network medicine will provide
a platform to methodically dissect molecular complexity of a par-
ticular disease. This may allow both identification of common
molecular underpinnings of differing phenotypes, as well as iden-
tification of divergent molecular mechanisms that may underlie
clinically similar phenotypes. Such molecular phenotypes will
allow more precise diagnosis and more targeted therapies and
treatments.
Similarly, another tool -genomic DNA footprinting- enables
mapping of millions of in vivo binding sites for hundreds of
transcription factors simultaneously in primary human cells
(Lazarovici et al., 2013). The tools target a key bottleneck lim-
iting construction of comprehensive regulatory networks for
human cells typically requiring one-by-one or few-by-few dis-
covery of connections between transcriptional regulators. The
resulting maps enable the construction of accurate, comprehen-
sive transcriptional regulatory networks that can, identify key
regulatory factors for biological processes, help map networks
associated with specific disease states and pinpoint specific reg-
ulatory factors that play a pathogenic role in disease (Maurano
et al., 2012).
Finally, these emerging areas show the promise that systems
biology approaches hold to help address key biomedical research
challenges. The NHLBI programs have proven effective in foster-
ing the development and application of these approaches across
a wide range of areas, and we look forward to the day when
researchers readily/keenly accept such quantitative approaches as
part of a robust research strategy, just as DNA sequencing or RNA
expression has become a common activity in biomedical research
and not the sole domain of a few experts.
The views expressed by PQ and JL in this commentary
are personal and do not necessarily represent those of the US
Government.
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